ELVIRA KHAIMOV

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ASTORIA, NY NPI 1174294375

General Payments — all program years on this page

$1,735.19

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $481.93 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $481.9322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $218.214
2023 $1,035.0531
2024 $481.9322

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078103358 Janssen Pharmaceuticals, Inc $15.47 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078103400 Janssen Pharmaceuticals, Inc $19.29 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087023534 Novartis Pharmaceuticals Corporation $29.07 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087023538 Novartis Pharmaceuticals Corporation $27.75 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087023556 Novartis Pharmaceuticals Corporation $20.01 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087023560 Novartis Pharmaceuticals Corporation $22.03 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101686101 E.R. Squibb & Sons, L.L.C. $18.66 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101686127 E.R. Squibb & Sons, L.L.C. $14.33 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104634719 AstraZeneca Pharmaceuticals LP $29.06 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803684 Amgen Inc. $19.70 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803693 Amgen Inc. $10.46 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803701 Amgen Inc. $14.06 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803710 Amgen Inc. $26.75 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803720 Amgen Inc. $17.34 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803729 Amgen Inc. $22.11 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115803739 Amgen Inc. $18.70 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117596972 Amgen Inc. $23.95 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117596974 Amgen Inc. $22.56 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117596976 Amgen Inc. $18.90 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124881236 Abbott Laboratories $28.58 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152989925 ShockWave Medical, Inc $27.72 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154052737 iRhythm Technologies, Inc. $35.43 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.